Article Details

BioNTech initiates clinical trial of mRNA-based malaria vaccine candidate

Retrieved on: 2022-12-23 23:41:17

Tags for this article:

Click the tags to see associated articles and topics

BioNTech initiates clinical trial of mRNA-based malaria vaccine candidate. View article details on hiswai:

Excerpt

BERLIN: BioNTech has initiated a first in human Phase 1 clinical trial of its BNT165b1 malaria vaccine candidate using mRNA technology, ...

Article found on: thepeninsulaqatar.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up